Sign Up to like & get
recommendations!
0
Published in 2019 at "Drug Safety"
DOI: 10.1007/s40264-019-00839-w
Abstract: IntroductionTafenoquine has been recently registered for the prevention of relapse in Plasmodium vivax malaria.ObjectiveThis study assessed the pharmacodynamic effects of 300-mg single-dose tafenoquine on the retina.MethodsThis phase I, prospective, multicenter, randomized, single-masked, placebo-controlled, parallel-group study…
read more here.
Keywords:
placebo;
ophthalmic safety;
dose tafenoquine;
tafenoquine ... See more keywords